Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: The effects of molnupiravir in treating patients with non-severe COVID-19 remain uncertain. OBJECTIVES: To evaluate the efficacy and safety of molnupiravir in adult patients with mild or moderate COVID-19. DATA SOURCES: PubMed, Embase, CENTRAL, Web of Science, and WHO COVID-19 database u...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ya, Liu, Ming, Li, Zhifan, Xu, Jianguo, Zhang, Junhua, Tian, Jinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116122/
https://www.ncbi.nlm.nih.gov/pubmed/37084941
http://dx.doi.org/10.1016/j.cmi.2023.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116122/
https://www.ncbi.nlm.nih.gov/pubmed/37084941
http://dx.doi.org/10.1016/j.cmi.2023.04.014

Ejemplares similares